Tuesday, January 3, 2023
11:31 AM EST – Marvel Biosciences Corp : Announces it has successfully completed its dose-ranging toxicology studies in rats and dogs, for its lead drug candidate MB-204. These studies will assist in determining the doses for the IND-enabling 4-week GLP toxicology studies. Marvel Biosciences Corp (V.MRVL) shares were up one cent at 0.13.
Stocks in Play: Marvel Biosciences Corp, Tue, 03 Jan 2023 11:42:07 EST